ftc-istock-530746621-rivernorthphotography
RiverNorthPhotography / iStockphoto.com
24 February 2017Americas

Abbott’s $25bn St. Jude acquisition would be anti-competitive, says FTC

The Federal Trade Commission (FTC) has found after a public comment period that Abbott Laboratories’ $25 billion acquisition of St. Jude Medical would probably be anti-competitive.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
29 March 2017   Last year was a historic one for the US Federal Trade Commission, according to its “Annual Highlights” report, issued yesterday.
Americas
18 September 2017   The Federal Trade Commission has secured a partial victory in its competition case against life sciences company AbbVie.

More on this story

Americas
29 March 2017   Last year was a historic one for the US Federal Trade Commission, according to its “Annual Highlights” report, issued yesterday.
Americas
18 September 2017   The Federal Trade Commission has secured a partial victory in its competition case against life sciences company AbbVie.

More on this story

Americas
29 March 2017   Last year was a historic one for the US Federal Trade Commission, according to its “Annual Highlights” report, issued yesterday.
Americas
18 September 2017   The Federal Trade Commission has secured a partial victory in its competition case against life sciences company AbbVie.